相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。From a Library of MAG Antagonists to Nanomolar CD22 Ligands
Stefanie Mesch et al.
CHEMMEDCHEM (2012)
Targeting B lymphoma with nanoparticles bearing glycan ligands of CD22
Weihsu C. Chen et al.
LEUKEMIA & LYMPHOMA (2012)
Targeting Siglecs-A novel pharmacological strategy for immuno- and glycotherapy
Camilla Jandus et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Supramolecular Complexing of Membane Siglec CD22 Mediated by a Polyvalent Heterobifunctional Ligand that Templates on IgM
Lina Cui et al.
BIOCONJUGATE CHEMISTRY (2011)
CD22-Antagonists with nanomolar potency: The synergistic effect of hydrophobic groups at C-2 and C-9 of sialic acid scaffold
Hajjaj H. M. Abdu-Allah et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
A Fragment-Based In Situ Combinatorial Approach To Identify High-Affinity Ligands for Unknown Binding Sites
Sachin V. Shelke et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2010)
In vivo targeting of B-cell lymphoma with glycan ligands of CD22
Weihsu C. Chen et al.
BLOOD (2010)
Cancer Statistics, 2010
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Kinetic and thermodynamic properties of MAG antagonists
Stefanie MeschA et al.
CARBOHYDRATE RESEARCH (2010)
Sialic acid dependence in rotavirus host cell invasion
Thomas Haselhorst et al.
NATURE CHEMICAL BIOLOGY (2009)
Design, Synthesis, and Structure-Affinity Relationships of Novel Series of Sialosides as CD22-Specific Inhibitors
Hajaj H. M. Abdui-Allah et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Synthesis of sialic acid derivatives as ligands for the myelin-associated glycoprotein (MAG)
Sachin V. Shelke et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
Crystallographic and in silico analysis of the sialoside-binding characteristics of the Siglec sialoadhesin
Nathan R. Zaccai et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Structure-guided design of sialic acid-based Siglec inhibitors and crystallographic analysis in complex with sialoadhesin
NR Zaccai et al.
STRUCTURE (2003)
NMR Spectroscopy techniques for screening and identifying ligand binding to protein receptors
B Meyer et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2003)
The ligand-binding domain of CD22 is needed for inhibition of the B cell receptor signal, as demonstrated by a novel human CD22-specific inhibitor compound
S Kelm et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
分享论文
